Cyclo Therapeutics to Participate in the H.C. Wainwright Global Investment Conference

Author's Avatar
May 18, 2022

Cyclo+Therapeutics%2C+Inc. (Nasdaq: CYTH) (“Cyclo Therapeutics” or the “Company”), a late clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families living with diseases, today announced that N.+Scott+Fine%2C+Chief+Executive+Officer+of+Cyclo+Therapeutics, will present at the H.C.+Wainwright+Global+Investment+Conference being held May 23-26, 2022 in Miami, FL and virtually.